CRY2 and neoplasm: Nearly ten years later, another unexpected regulatory function between FBXL3 and CRY2 is found that FBXL3 in cooperation with CRY2 targets an oncogenic substrate c-Myc to inhibit uncontrolled tumor cell growth 50.